The glymphatic system is a CSF-mediated waste clearance pathway that is formed by astroglial cells. The removal of potentially harmful substances such as amyloid protein is important to prevent toxic levels accumulate in the brain. Discover the latest research on glymphatics here.

December 5, 2020
Open Access

Peristaltic flow in the glymphatic system

Scientific Reports
Francesco RomanòJames B Grotberg
January 1, 2021
Open Access

Sleep Deprivation and Neurological Disorders

BioMed Research International
Muhammed BishirDavid J Ojcius
January 8, 2021
Open Access

Dysfunction of the Glymphatic System Might Be Related to Iron Deposition in the Normal Aging Brain

Frontiers in Aging Neuroscience
Wei ZhouJing-Jing Fei
December 29, 2020
Open Access

Direct Measurement of Cerebrospinal Fluid Production in Mice

Cell Reports
Guojun LiuMaiken Nedergaard
January 6, 2021

Hyperintense areas in the intraorbital optic nerve evaluated by T2-weighted magnetic resonance imaging: a glymphatic pathway?

Surgical and Radiologic Anatomy : SRA
Satoshi TsutsumiHisato Ishii
December 6, 2020

A Tridomain Model for Potassium Clearance in Optic Nerve

Yi ZhuHuaxiong Huang
November 15, 2020

L-3-n-Butylphthalide Effectively Improves the Glymphatic Clearance and Reduce Amyloid-β Deposition in Alzheimer's Transgenic Mice

Journal of Molecular Neuroscience : MN
Bo ZhangSheng Tan
January 9, 2021
Open Access

Decoupling of global brain activity and cerebrospinal fluid flow in Parkinson's cognitive decline

BioRxiv : the Preprint Server for Biology
F. HanXiao Liu
January 21, 2021

Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease.

Movement Disorders : Official Journal of the Movement Disorder Society
Erin K DonahueFarshid Sepehrband
January 16, 2021
Open Access

An immunohistochemical study of lymphatic elements in the human brain

Proceedings of the National Academy of Sciences of the United States of America
Éva MezeyMiklós Palkovits
November 21, 2020
Open Access

The Sleeping Brain: Harnessing the Power of the Glymphatic System through Lifestyle Choices

Brain Sciences
Oliver Cameron Reddy, Ysbrand D van der Werf
January 1, 2021
Open Access

Magnetic resonance imaging biomarkers of cerebrospinal fluid tracer dynamics  in idiopathic normal pressure hydrocephalus

Brain Communications
Per Kristian EideGeir Ringstad
November 11, 2020
Open Access

Surface periarterial spaces of the mouse brain are open, not porous

Journal of the Royal Society, Interface
Fatima Min RivasDouglas H Kelley
November 17, 2020
Comment / Editorial
Open Access

Editorial: Role of Astrocytes in Seizures Induced by Traumatic Brain Injury

Frontiers in Neurology
Fushun WangJason H Huang
December 20, 2020

The Cerebro-Renal System- Anatomical and Physiological Considerations

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Kumar Rajamani
December 15, 2020
Open Access

Stagnation of glymphatic interstitial fluid flow and delay in waste clearance in the SOD1-G93A mouse model of ALS

Neuroscience Research
Mikako HiroseHidemi Misawa
January 20, 2021
Open Access

Achieving brain clearance and preventing neurodegenerative diseases-A glymphatic perspective

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Tekla Maria KylkilahtiIben Lundgaard

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved